Bioinks are formulations of biomaterials and living cells, sometimes with growth factors or
other biomolecules, while extrusion bioprinting is an emerging technique to apply or deposit …

Effort invested in the development of new drugs often fails to be translated into meaningful
clinical benefits for patients with cancer. The development of more effective anticancer …

Bioprinting shows excellent potential for preclinical tumor modeling, with significant
advantages over 2D cell cultures in replicating the tumor microenvironment (TME). Recently …

Microfluidics describes the study of systems that operate fluids at miniature scales, often in
microchannels. It is powerful in scaling down biological experiments by many orders of …

The ability to promote three‐dimensional (3D) self‐organization of induced pluripotent stem
cells into complex tissue structures called organoids presents new opportunities for the field …

Three-dimensional (3D) bioprinting technologies involving photopolymerizable bioinks
(PBs) have attracted enormous attention in recent times owing to their ability to recreate …

Abstract 3D bioprinting is revolutionizing the fields of personalized and precision medicine
by enabling the manufacturing of bioartificial implants that recapitulate the structural and …

Cellular, extracellular matrix (ECM), and spatial heterogeneity of tumor microenvironments
(TMEs) regulate disease progression and treatment efficacy. Developing in vitro models that …

Abstract Three-dimensional (3D) bioprinting is a novel technology that enables the creation
of 3D structures with bioinks, the biomaterials containing living cells. 3D bioprinted …

Inflammation is activated by diverse triggers that induce the expression of cytokines and
adhesion molecules, which permit a succession of molecules and cells to deliver stimuli and …